COVID Information: Review our current visitor policies or visit the COVID-19 Resource Center. *For everyone’s safety, masks are required at all times in our facilities. Thank you.

Kearney Regional Medical Center is the first in the area to utilize a new technology to help treat critically ill patients.

On Thursday, Dr. John Allen placed a small port under a patient’s skin that will diminish the need for regular IV sticks as a part of their ongoing treatment therapy plan.

The device, called a “PowerFlow®,” is the first implantable product specifically designed for therapeutic apheresis treatments, used to treat a variety of disorders within the body.

“Apheresis” involves the removal of whole blood from an individual, separating it into components and removing defective cells, and returning the remaining components to the patient.

The treatment has become a relatively common modality nationwide. According to the US National Library of Medicine, there is increasing evidence for using apheresis to treat various diseases such as blood disorders, drug toxicities, autoimmune diseases, sepsis and acute liver failure.[1]

The new product will allow doctors repeated access to the vascular system to perform the ongoing apheresis treatments.

Outside of Kearney Regional Medical Center, the new technology is currently only being used by the University of Nebraska Medical Center in the state of Nebraska.

You can learn more about the new device and how it’s being used in this story from NTV News.